Management and prognosis of breast cancer through FDG PET/CT
Not Applicable
- Conditions
- Health Condition 1: null- Breast Cancer (Retrospective data of Breast Cancer Patients will be collected)
- Registration Number
- CTRI/2012/09/002966
- Lead Sponsor
- ot applicable Thesis Protocol
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
Female breast cancer patients referred for 18[F] FDGPET/CT scan in the Nuclear Medicine Department of Max Super Speciality Hospital.
Exclusion Criteria
Patient clinical data not available.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the indication for 18[F] FDG PET/CT for breast cancer patients, used by Oncologist in Max Super Speciality Hospital: <br/ ><br>a)Diagnosis <br/ ><br>b)Staging <br/ ><br>c)Recurrence/Metastasis (Restaging) <br/ ><br>d)Treatment response evaluation <br/ ><br>e)Radiation treatment response <br/ ><br>Timepoint: Indication of 18[F] FDG PET/CT for breast cancer patients: <br/ ><br>a)Diagnosis <br/ ><br>b)Staging <br/ ><br>c)Recurrence/Metastasis (Restaging) <br/ ><br>d)Treatment response evaluation <br/ ><br>e)Radiation treatment response <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.To determine 18[F] FDG PET/CT effectiveness in the evaluation of chemotherapy response by calculating the percentage decrease in SUV value from the baseline value (Pre-therapy scan). <br/ ><br>2. To determine the impact of 18[F] FDG PET/CT on the treatment management plan, whether altered or supported. <br/ ><br>3. To determine the most common metastatic site in the metastatic breast cancer patients. <br/ ><br>Timepoint: 1.Percentage decrease in SUV value (post-therapy scan) from the baseline value (Pre-therapy scan). <br/ ><br>2.Change in the treatment management plan. <br/ ><br>3. Most common metastatic site in the metastatic breast cancer patients. <br/ ><br>